In a recent study by Fortea et al. (2020), a trend of increased levels of both plasma and CSF NFL in DS patients with AD when compared to healthy DS patients and healthy aged-matched controls was reported [74], as well as in the paper by Fagan and colleagues (2022) [27]. This evidence concerns the gene NEFL and Alzheimer disease.